June 6, 2025PFIZER INC. PFE Partners with Acepodia, Innovating Cancer Treatments ~1 min.Pfizer Inc. announced a new partnership with Acepodia to develop cutting-edge cancer treatments....
April 4, 2025PFIZER INC. Hits Forecast Price Target with 7.0% Profit - QuantWave Analysis ~1 min.PFIZER INC. has successfully achieved the price target forecast set by QuantWave, with a profit of 7.0%. The forecast signal was issued on April 2, 2025, at a price of 24.24 $....
April 3, 2025PFIZER INC. Hits Price Target Forecast with 7.05% Profit ~1 min.QuantWave's forecast for PFIZER INC. proved to be successful as the stock reached the predicted target price of 23.84 $ on April 3, 2025, from the initial signal date of May 7, 2024, when the price was at 25....
March 27, 2025With 67 ownership Pfizer Inc. NYSE:PFE boasts of strong institutional backing ~1 min.Pfizer Inc., a renowned pharmaceutical company, is currently enjoying the support of strong institutional investors with a significant 67% ownership....
March 21, 2025Analyst Says Pfizer PFE Stock Will Move Too Fast to Catch ~1 min.According to recent analysis by Stocks Prognosis, Pfizer Inc. (NYSE:PFE) is expected to experience significant movement in its stock price in the near future....
December 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential ~2 min.AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....
February 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry ~2 min.Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....
January 15, 2025AbbVie Inc. ABBV: A Company Attracting Investor Attention ~2 min.AbbVie Inc. (NYSE: ABBV) has been gaining significant investor attention lately, and for good reason....
December 3, 2024AbbVie Inc. Continues to Impress with Strong Financial Performance ~1 min.With 73% ownership in AbbVie Inc., institutional investors have a lot riding on the business, making it one of the most attractive pharmaceutical stocks to buy....
January 25, 2025Is GSK plc GSK an Undervalued Defensive Stock for 2025? ~2 min.GSK plc (NYSE: GSK) has been gaining attention as a potential undervalued defensive stock for investors looking towards 2025....
